Director or Senior Director of in vitro Biology
桑迪亚医药技术(上海)有限责任公司
- 公司性质:外资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2019-11-12
- 工作地点:上海-浦东新区
- 招聘人数:1人
- 工作经验:5-7年经验
- 学历要求:博士
- 职位月薪:2.5-4万/月
- 职位类别:生物工程/生物制药 医药技术研发管理人员
职位描述
Responsibility:
1. The successful candidate will have deep understanding of Molecular Biology, Biochemistry or related field and hands-on experience of automated in vitro bioassay.
2. Take responsibilities in developing biochemical and cellular assays and providing in vitro screening support. The related activities include designing, validating, executing and troubleshooting experiments, coordinating and leading research project.
3. Communicating with clients on daily basis. Writing and editing technical reports. Trouble shooting protocols and ensure on-time delivery of the study results.
4. Lead the in vitro biology team and providing daily people management of the team. Responsible of technical training of the new and experienced employees and help to solve any issues or conflict among team members.
5. Participate in business development activities including visiting and hosting clients. Actively searching potential new clients and try to meeting client’s need in bioassay development and validation.
Requirement:
1. Education: PhD degree in Molecular Biology, biochemistry or related disciplines and at least 8 years of oversea working experience in pharma industry.
2. Hands-on experience in developing, validating and executing plate-based and biochemical assays, both kinetic and binding assays.
3. Familiar with integrate/automated devices to improve assay throughput and robustness.
4. An ability to independently generate precise, reliable data and skillfully analyze and interpret it.
5. Good people management skill, with prior experience of leading a group of at least 5 people.
6. Good written and oral communication skill in both English and Chinese.
职能类别:生物工程/生物制药医药技术研发管理人员
公司介绍
保诺-桑迪亚,安宏资本旗下投资企业之一,是业内领先的合同研究、工艺开发和生产公司 (CRDMO),专业为生物制药客户提供全面整合服务,支持药物发现、开发和生产(包括原料药和成品药)。作为全球第三大 CRDMO 公司,保诺-桑迪亚的 10 大办事处遍布全球,旗下拥有 2000 多名员工,在中国和美国开展主要业务。
保诺-桑迪亚在大小分子发现、开发和放大方面拥有核心专业知识,支持 IND 申报,拥有独特的专利技术平台(例如不溶性化合物生物利用度增强平台)。公司在中国和美国均设有研发中心和生产基地。保诺-桑迪亚采用“一站式”运营模式,有效帮助生物制药客户加快发现进程并降低开发风险,从而创造更高价值的药物。
保诺-桑迪亚由安宏资本领投,Bridgewest Business Group 为共同投资者。
联系方式
- Email:xhsun@sundia.com